---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-001223"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T17:20:39.901738+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Eterna Therapeutics transfers Nasdaq listing to Capital Market, effective Jan 11, 2023

## Summary
- Nasdaq Staff approved transfer from Global Market to Capital Market on Jan 9, 2023.
- Common stock begins trading on Capital Market at open on Jan 11, 2023 under symbol ERNA.
- Company voluntarily applied for transfer on Jan 2, 2023 (previously reported).
- Capital Market has similar corporate governance requirements but different financial listing standards.

## SEC filing metadata
- accession: 0001140361-23-001223
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000114036123001223/0001140361-23-001223-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000114036123001223/brhc10046500_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-001223
- JSON: https://secwatch.observer/filing/0001140361-23-001223.json
- Plain text: https://secwatch.observer/filing/0001140361-23-001223.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.